The Celgene Corporation has released its annual Corporate Responsibility Report, Bold Science to Benefit Patients.
The global bio-pharmaceutical corporation is focused on the discovery and development of products for the treatment of cancer and other severe, immune, inflammatory conditions. It’s responsibility report discusses its commitments to patients, the community and its own integrity.
“At Celgene, bold science that benefits patients is at the core of our values and our business,” the company states. “Each year, Celgene’s cutting-edge medical research helps more patients around the world. While patients are the focus of our mission, we also take very seriously our responsibilities to our employees, our communities and our environment—responsibilities that we continue to live up to. Celgene’s 2018 Corporate Responsibility Report, released this week, highlights how we are working to make a difference in the lives of patients, communities and economies around the world.”